EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous Improvement of Frontal Rhytids Following Glabella Only Treatments With Neuromodulators—A Clinical Prospective Pilot Study

Victor R M Munoz-Lora iD, Victor Rogerio, Vanessa Thiesen, Ana C N Carnevali, Carlos Bravo iD, Sachin M Shridharani iD, David Eccleston, Michael Alfertshofer iD, Marcelo Germani, Sebastian Cotofana iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Victor R M Munoz-Lora und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology and Implantology, University of Guarulhos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Skin Aging, Botulinum Toxins, Type A, Neuromuscular Agents, Cosmetic Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

While traditionally focused on treating glabellar and forehead rhytids through direct neuromodulator injections, recent findings on the biomechanics of facial muscles suggest that glabellar treatments alone may influence forehead wrinkles by altering the dynamic balance between depressor and elevator muscles.

Objective

To evaluate whether glabellar‐only neuromodulator treatments can reduce forehead wrinkle severity without direct injections into the frontalis muscle.

Methods

This prospective, interventional study included 18 participants with moderate to very severe glabellar lines. Neuromodulator (AbobotulinumtoxinA; 37.5 sU (= 15 IU)) injections were administered exclusively in the glabella at three intervals over 7 months. Glabellar Severity Scale (GLSS), Forehead Wrinkle Scale (FWS), Frontal Skin Displacement (FSD), and Eyebrow Position Scoring (EPS) were assessed at baseline and 30 days after each cycle.

Results

GLSS scores significantly improved across treatment cycles (baseline: 3.0; post‐third cycle: 1.0; p < 0.001). FWS improved from 3.0 at baseline to 1.0 after the third cycle ( p = 0.005), while FSD showed a significant reduction from 37.2 mm to 17.9 mm ( p < 0.01). No changes in eyebrow position were detected following EPS assessment.

Conclusion

Glabellar‐only neuromodulator treatments with 37.5 sU (= 15 IU) effectively reduced forehead rhytid severity, likely by altering the balance between depressor and elevator muscles. This approach minimizes risks associated with direct frontalis injections and offers a novel strategy for forehead rejuvenation. Moreover, the observed progressive improvement across treatment cycles suggests that this strategy may continuously enhance aesthetic outcomes over time, supporting the rationale for maintenance treatments at regular intervals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin AgingBotulinum Toxins, Type ANeuromuscular AgentsCosmetic TechniquesHumansPilot ProjectsProspective StudiesFemaleForeheadMiddle AgedFacial MusclesMaleTreatment OutcomeAdultAgedEyebrows

Stichwörter der Autor:innen

facial aestheticsfacial biomechanicsforehead linesglabellar linesneuromodulator treatments

Substanzen

Botulinum Toxins, Type AabobotulinumtoxinANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Periodontology and Implantology, University of Guarulhos, São Paulo, Brazil.
  • Let's HOF Academy, São Paulo, Brazil.
  • Private Practice, Sao Paulo, Brazil.
  • Private Practice, San Jose, Costa Rica.
  • Division of Plastic and Reconstructive Surgery, Washington University, St. Luis, Missouri, USA.
  • Private Practice, New York, New York, USA.

ORCID-Profile: Victor R M Munoz-Lora, Carlos Bravo, Sachin M Shridharani, Michael Alfertshofer, Sebastian Cotofana

Zitieren

APA

Munoz-Lora, V. R. M., Rogerio, V., Thiesen, V., Carnevali, A. C. N., Bravo, C., Shridharani, S. M., Eccleston, D., Alfertshofer, M., Germani, M., & Cotofana, S. (2025). Continuous Improvement of Frontal Rhytids Following Glabella Only Treatments With Neuromodulators—A Clinical Prospective Pilot Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70188

Vancouver

Munoz-Lora VRM, Rogerio V, Thiesen V, Carnevali ACN, Bravo C, Shridharani SM, et al. Continuous Improvement of Frontal Rhytids Following Glabella Only Treatments With Neuromodulators—A Clinical Prospective Pilot Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70188

BibTeX
@article{MunozLora2025,
  author = {Munoz-Lora, Victor R M and Rogerio, Victor and Thiesen, Vanessa and Carnevali, Ana C N and Bravo, Carlos and Shridharani, Sachin M and Eccleston, David and Alfertshofer, Michael and Germani, Marcelo and Cotofana, Sebastian},
  title = {Continuous Improvement of Frontal Rhytids Following Glabella Only Treatments With Neuromodulators—A Clinical Prospective Pilot Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70188}
}
Kostenlos starten →